Home/ Supplements/ Vitamin E/ Feminene Female Support Formula

Feminene Female Support Formula

product on market Tablet or Pill Market America Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 60% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The formula contains B vitamins and Vitamin E, which support cellular energy metabolism and antioxidant functions. Research provides strong evidence for the roles of these nutrients in general physiological health. However, overall evidence coverage for this specific combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Feminene Female Support Formula
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
30
Servings
Botanical with Nutrients
Product Type
60%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

50 IU (167% DV)
2.2× RDA — within safe limits 179 studies (A:3, B:90)
20 mg (1333% DV)
16.7× RDA — above typical dose 76 studies (A:0, B:33)
20 mg (1176% DV)
15.4× RDA — above typical dose 13 studies (A:0, B:1)
20 mg (100% DV)
1.4× RDA — within safe limits 196 studies (A:5, B:63)
10 mg (500% DV)
7.7× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
400 mcg (100% DV)
Within RDA (1.0× RDA) 226 studies (A:10, B:105)
200 mcg (3333% DV)
83.3× RDA — above typical dose 139 studies (A:1, B:44)
11.8 mg (118% DV)
Market median: 4002.0mg (1 products) 21 studies (A:0, B:2)
200 mg
Market median: 60.0mg (94 products) 13 studies (A:0, B:7)
Dong Quai
200 mg
Evening Primrose Oil
200 mg
Wild Yam
180 mg
Market median: 80.0mg (136 products)
Chasteberry extract
150 mg
Horsetail
150 mg
Red Clover
140 mg
120 mg
Market median: 250.0mg (60 products) 7 studies (A:0, B:1)
120 mg
Market median: 300.0mg (214 products) 25 studies (A:0, B:6)
100 mg
Market median: 500.0mg (82 products) 19 studies (A:1, B:6)
Market median: 300.0mg (240 products) 20 studies — no high-quality reviews

Other Ingredients

Dicalcium Phosphate Microcrystalline Cellulose Magnesium Stearate Croscarmellose Sodium Silica Hydroxypropyl Methyl Cellulose Polyethylene Titanium Dioxide Titanium Dioxide FD&C Yellow #6
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommended Serving: As a dietary supplement for women in menopause or with PMS, take 2 tablets with 8 fl. oz. of water 30 minutes before a meal.

Warnings & Precautions

KEEP OUT OF THE REACH OF CHILDREN.

Do not use if the safety seal is broken or missing.

WARNING: This product may reduce the effectiveness of some prescription medications, especially those metabolized by cytochrome P-450 enzymes. These prescription medications would include, but are not limited to, Paxil, Zoloft, Prilosec, Allegra, Zofran, Lipitor, and NSAIDs such as ibuprofen. Women with breast cancer or other estrogen-sensitive cancers or those taking monoamine oxidase-inhibiting (MAOI) or anticoagulant/antiplatelet medications should not use this product. This product may reduce the effectiveness of contraceptive drugs. Use of alcohol with this product may cause drowsiness. If you are taking any prescription medications or have an ongoing medical condition, you should consult your physician before taking this product.

Formulation Notes

CONTAINS: SOY

Additional Information

Store tightly sealed in a cool, dry location and protect from light.

Lot #: Best when used by:

Made in the USA

marketamerica Built on Product. Powered by People.

REV 808

Metadata

Product Details

DSLD Entry Date2012-02-23
Product TypeBotanical with Nutrients
FormTablet or Pill
DSLD ID6185
Data Updated2026-04-11
Research

Research Evidence

253
Research Sources
55
Avg Quality
128
Meta Analysis
52
Systematic Review
41
Rct
24
Clinical Trial
3
Regulatory Source
1
Narrative Review
1
Other
1
Guideline
1
Openfda Safety
A Vitamin E supplementation in pregnancy
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin E for Alzheimer's dementia and mild cognitive impairment
Systematic Review The Cochrane database of systematic reviews 2017 PubMed DOI
A Vitamin E for Alzheimer's disease and mild cognitive impairment
Meta Analysis The Cochrane database of systematic reviews 2008 PubMed DOI
A Vitamin E for Alzheimer's dementia and mild cognitive impairment
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Exercise for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Effects of vitamin E supplementation on the risk and progression of AD: a systematic review and meta-analysis
Meta Analysis Nutritional neuroscience 2021 PubMed DOI
A Effect of vitamin E supplementation in rheumatoid arthritis: a systematic review and meta-analysis
Meta Analysis European journal of clinical nutrition 2023 PubMed DOI
A Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Rct JAMA 2011 PubMed DOI
A Vitamin E for Alzheimer's dementia and mild cognitive impairment
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
B Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement.
Guideline JAMA 2022 PubMed DOI
View all evidence for Vitamin E →
Compare

Similar Products

View all Vitamin E products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.